Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Centre de recherche du Centre hospitalier universitaire de Sherbrooke clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada register with Centre de recherche du Centre hospitalier universitaire de Sherbrooke as lead sponsor. Synced 17 Nov 2026
6Current trials
5Recruiting now
0Drugs in these trials
1Trial register
At a glance

Centre de recherche du Centre hospitalier universitaire de Sherbrooke is the lead sponsor of 6 current clinical trials in our Canada register. 5 are recruiting patients now. The most common phase is Phase 2. The most-studied condition is Neuroblastoma.

ClinicalTrials.gov trials by status

  • Recruiting583%
  • Active, closed117%

Trials by phase

  • Phase 2350%
  • Not applicable117%
  • Phase 1/2117%
  • Observational117%
01

Clinical trials sponsored by Centre de recherche du Centre hospitalier universitaire de Sherbrooke

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
68Ga-DOTATATE Neuroblastoma Imaging Pilot
NCT04559217 · ClinicalTrials.gov ↗ · Neuroblastoma
Phase 2 Recruiting 2021-12 Canada
4FMFES-PET Imaging of ER+ Advanced Breast Cancers
NCT04824014 · ClinicalTrials.gov ↗ · ER+ Breast Cancer
Phase 2 Recruiting 2020-11 Canada
Thyroid Artery Embolization for the Treatment of Compressive Goiters.
NCT07360587 · ClinicalTrials.gov ↗ · Thyroid Nodules
Not applicable Recruiting 2026-05 Canada
HER2-PET Imaging in HER2-low Breast Cancers
NCT06732336 · ClinicalTrials.gov ↗ · Breast Cancer Metastatic
Phase 1/2 Recruiting 2024-12 Canada
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05228106 · Solid Cancers
Observational Recruiting 2022-01 Canada
68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy
NCT05214820 · ClinicalTrials.gov ↗ · Upper Digestive Tract Cancer
Phase 2 Active, closed 2022-01 Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Centre de recherche du Centre hospitalier universitaire de Sherbrooke trials

6 conditions
Neuroblastoma1Upper Digestive Tract Cancer1ER+ Breast Cancer1Thyroid Nodules1Breast Cancer Metastatic1Solid Cancers1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Canada65

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Neuroblastoma

SponsorTrials
Giselle Sholler4
Institut Curie3
The General Hospital of Western Theater Command1
Sun Yat-Sen University Cancer Center1
Milton S. Hershey Medical Center1

Sponsors with the most current trials registered for this condition.

05

Questions about Centre de recherche du Centre hospitalier universitaire de Sherbrooke trials

How many clinical trials does Centre de recherche du Centre hospitalier universitaire de Sherbrooke sponsor?

Centre de recherche du Centre hospitalier universitaire de Sherbrooke is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Canada register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Centre de recherche du Centre hospitalier universitaire de Sherbrooke trials recruiting?

Yes. 5 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.